Rite Aid Reports Q2 Adjusted Loss Per Share $0.41 From Cont Ops.

Q2 ADJUSTED LOSS PER SHARE $0.41 FROM CONTINUING OPERATIONS .
Q2 LOSS PER SHARE FROM CONTINUING OPERATIONS $1.86.
ORATION REPORTS FISCAL 2022 SECOND QUARTER RESULTS AND RAISES FULL YEAR ADJUSTED EBITDA GUIDANCE.
Q2 REVENUE $6.11 BILLION VERSUS REFINITIV IBES ESTIMATE OF $6.21 BILLION.
Q2 EARNINGS PER SHARE ESTIMATE $-0.48 -- REFINITIV IBES DATA.
SEES FY ADJUSTED LOSS PER SHARE $0.53 TO $0.90.
REVENUES ARE EXPECTED TO BE BETWEEN $25.1 BILLION AND $25.5 BILLION IN FISCAL 2022.
QTRLY RETAIL PHARMACY SEGMENT REVENUES FROM CONTINUING OPERATIONS INCREASED 6.5 PERCENT OVER PRIOR YEAR QUARTER.
PHARMACY SERVICES SEGMENT REVENUE IS EXPECTED TO BE BETWEEN $7.7 BILLION AND $7.8 BILLION IN 2022.
FY2022 EARNINGS PER SHARE VIEW $-0.63, REVENUE VIEW $25.13 BILLION -- REFINITIV IBES DATA.
FISCAL 2022 ADJUSTED EBITDA IS EXPECTED TO BE BETWEEN $460 MILLION AND $500 MILLION.
Rite Aid Q2 Adjusted Loss Per Share $1.86 From Continuing Operations.

Q2 ADJUSTED LOSS PER SHARE $1.86 FROM CONTINUING OPERATIONS.